Clinical Trial Update: A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the Neovista Ophthalmic System for treating subfoveal CNV in wet age-related macular degeneration patients who failed primary anti-VE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• Neovista Ophthalmic System

Snippet

Sponsor: NeoVista | Conditions: Wet Age-related Macular Degeneration | Phase 2 | Status: COMPLETED